These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12392060)

  • 21. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
    Geist RT; Reddy AJ; Zhang J; Gutmann DH
    Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain abnormalities in tuberous sclerosis complex.
    DiMario FJ
    J Child Neurol; 2004 Sep; 19(9):650-7. PubMed ID: 15563010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.
    Wong M; Ess KC; Uhlmann EJ; Jansen LA; Li W; Crino PB; Mennerick S; Yamada KA; Gutmann DH
    Ann Neurol; 2003 Aug; 54(2):251-6. PubMed ID: 12891680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional changes in astroglial cells in epilepsy.
    Binder DK; Steinhäuser C
    Glia; 2006 Oct; 54(5):358-68. PubMed ID: 16886201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genes, plasticity and mental retardation.
    Vaillend C; Poirier R; Laroche S
    Behav Brain Res; 2008 Sep; 192(1):88-105. PubMed ID: 18329113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
    Sarnat HB; Flores-Sarnat L
    Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression changes in rat brain after short and long exposures to particulate matter in Los Angeles basin air: Comparison with human brain tumors.
    Ljubimova JY; Kleinman MT; Karabalin NM; Inoue S; Konda B; Gangalum P; Markman JL; Ljubimov AV; Black KL
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):1063-71. PubMed ID: 23688656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentially expressed genes after peripheral nerve injury.
    Gillen C; Gleichmann M; Spreyer P; Müller HW
    J Neurosci Res; 1995 Oct; 42(2):159-71. PubMed ID: 8568916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects.
    Connolly MB; Hendson G; Steinbok P
    Childs Nerv Syst; 2006 Aug; 22(8):896-908. PubMed ID: 16770618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats.
    Wang L; Shi J; Wu G; Zhou F; Hong Z
    Epilepsy Res; 2014 Nov; 108(9):1483-91. PubMed ID: 25205164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans.
    Williams SN; Locke CJ; Braden AL; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2004 Sep; 13(18):2043-59. PubMed ID: 15254012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex.
    Okanishi T; Akiyama T; Tanaka S; Mayo E; Mitsutake A; Boelman C; Go C; Snead OC; Drake J; Rutka J; Ochi A; Otsubo H
    Epilepsia; 2014 Oct; 55(10):1602-10. PubMed ID: 25196064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The neurobiological bases of epileptogenesis in the developing brain].
    Chepurnov SA; Chepurnova NE
    Usp Fiziol Nauk; 1997; 28(3):3-53. PubMed ID: 9381777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
    Waltereit R; Welzl H; Dichgans J; Lipp HP; Schmidt WJ; Weller M
    J Neurochem; 2006 Jan; 96(2):407-13. PubMed ID: 16300636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Ess KC; Kamp CA; Tu BP; Gutmann DH
    Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex single gene disorders and epilepsy.
    Merwick A; O'Brien M; Delanty N
    Epilepsia; 2012 Sep; 53 Suppl 4():81-91. PubMed ID: 22946725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving neurobiology of tuberous sclerosis complex.
    Crino PB
    Acta Neuropathol; 2013 Mar; 125(3):317-32. PubMed ID: 23386324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epileptogenic brain malformations: clinical presentation, malformative patterns and indications for genetic testing.
    Guerrini R; Carrozzo R
    Seizure; 2001 Oct; 10(7):532-43; quiz 544-7. PubMed ID: 11749114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.